Geoffrey Shapiro - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Geoffrey Shapiro

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2023

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 TrialDavid S Hong, Michael Postow, Bartosz Chmielowski, et al.

NPJ Precision Oncology|October 6, 2022

MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.

Lung Cancer (Amsterdam, Netherlands)|August 28, 2024

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2023

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 TrialDavid S Hong, Michael Postow, Bartosz Chmielowski, et al.

NPJ Precision Oncology|October 6, 2022

MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.

Lung Cancer (Amsterdam, Netherlands)|August 28, 2024

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.

Pageof 3